Diana M Gibb

24PUBLICATIONS
148CO-AUTHORS
HaematologyInfant and child healthDisease surveillanceMajor global burdens of diseaseMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 01, 2026
Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda.

|Jun 09, 2026
Cytomegalovirus Viremia Is Associated With Mortality Among Children With HIV Starting Antiretroviral Therapy in Sub-Saharan Africa.

|Jun 03, 2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

|Apr 13, 2026
Synthesis and Standardization of Outcomes in Severe Malaria Treatment Trials: Protocol for the Development of a Core Outcome Set (the COSSMaT Study).

Gideon Darko Asamoah, Sharon B Love, Diana M Gibb

|Apr 12, 2026
Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

James Wyncoll, Rujirek Kamolrattana, Moherndran Archary

|Feb 24, 2026
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.

Eva Natukunda, Alex J Szubert, Mutsa Bwakura-Dangarembizi

Pageof 4

Frequent Collaborators

6 joint publications

Ann Sarah Walker

4 joint publications

Chishala Chabala

4 joint publications

Alexander J Szubert

3 joint publications

Anna Turkova